Streetbeat News

ZEPP

Zepp Health Corporation

https://www.huami.com

Industry

Consumer Electronics

Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

Open

3.23

Mkt cap

48M

Volume

15K

High

3.39

P/E Ratio

-1.99

52-wk high

8.40

Low

3.23

Div yield

N/A

52-wk low

2.06

Zepp Health (NYSE:ZEPP) reported a Q1 adjusted loss of $(0.19) per ADS, significantly missing the analyst estimate of $(0.03). Sales also fell short at $39.80 million against the expected $46.24 million, marking a 57.64% year-over-year decline.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 9:04 pm

The article highlights the performance of 12 information technology stocks during Monday's after-market session. Notable gainers include Akoustis Technologies, Cheetah Mobile, Presto Automation, Inseego, Clearwater Analytics, and CSP. Significant losers include Rubicon Technologies, Zenvia, Mawson Infrastructure Group, Palo Alto Networks, Zepp Health, and DatChat.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 8:31 pm

Zepp Health Corporation received a NYSE non-compliance letter due to the low trading price of its ADSs, indicating it's below the required compliance standards.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 9:02 pm

Zepp Health Corporation (NYSE:ZEPP) announced the U.S. launch of the Amazfit Helio Ring on May 15th, 2024, priced at $299.99. The smart ring, awarded 'Best Fitness Wearable' at CES 2024, offers insights into athletic performance and recovery. It can be purchased alone or bundled with Amazfit smartwatches for enhanced data integration via the Zepp App. The product aims to redefine athletic recovery by providing comprehensive health monitoring and recovery insights.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 3:03 pm

Peraso Inc. reported worse-than-expected Q4 EPS results, causing its shares to fall by over 23%. Other stocks experienced significant movements, with notable gainers including Ontrak, Fusion Pharmaceuticals, and Spire Global, among others. Losers included Greenwave Technology Solutions, Seelos Therapeutics, and Comtech Telecommunications, with various reasons such as disappointing financial results, downgrades, and restructuring of debt.

Portfolio Pulse from Avi Kapoor

March 19, 2024 | 5:48 pm

In Tuesday's intraday session, several Information Technology stocks experienced significant movements. Notable gainers include BitFuFu, Movella Holdings, Spectaire Holdings, Veritone, Akoustis Technologies, and My Size, with increases ranging from 11.66% to 22.5%. On the downside, Comtech Telecom, Peraso, Zepp Health, Mercurity Fintech Holding, Presto Automation, and AEye saw declines between 13.6% and 27.4%, largely due to recent earnings releases.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 5:31 pm

Zepp Health's stock is trading lower following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 3:56 pm

Zepp Health projects its Q1 2024 revenue to be between $42M and $49M.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 9:12 pm

Zepp Health reported its Q4 2023 adjusted earnings per share (EPS) at $0.01, an improvement from a loss of $(0.14) year-over-year (YoY). However, its revenue for the quarter was $84.50 million, a decrease from $155.4 million YoY.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 9:11 pm

Zepp Health (NYSE:ZEPP) reported Q4 earnings with a significant miss on estimated earnings by -75.0%, posting an EPS of $0.01 against an estimate of $0.04. Revenue also saw a decrease, down $70.92 million from the same period last year. This follows a pattern of missed EPS estimates in previous quarters, with the company's share price experiencing a 0.0% change the day after last quarter's earnings were announced.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 9:10 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.